James Anthony Cannon is Director at ZIOPHARM ONCOLOGY INC (ZIOP). They have made 1 open-market trade across 1 company since 2009, most recently 2019-05-07.
CIK 0001338533
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $543K since 2009, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ZIOP | 398,050 | $345K |
Shares reported on the most recent Form 4, priced at the 2019-05-08 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ZIOP | BUY | 2009-12-09 | 2009-12-11 | $3.10 | $543K | -29.4% | -0.6% | -0.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.